These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10874458)

  • 21. Recombinant growth factors.
    Goodnough LT; Anderson KC
    Transfus Sci; 1995 Mar; 16(1):45-62. PubMed ID: 10155704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hematopoietic growth factors. Current status of therapy].
    Hiddemann W
    Internist (Berl); 1994 Apr; 35(4):395-400. PubMed ID: 7515381
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of hematopoietic growth factors in transfusion medicine.
    Goodnough LT
    Curr Opin Hematol; 1994 Nov; 1(6):462-70. PubMed ID: 9371324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of hematopoietic growth factors in transfusion medicine.
    Whitsett CF
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):23-68. PubMed ID: 7737944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical use of recombinant hematopoietic colony-stimulating factors.
    Shepro DS; Sullivan R
    Adv Intern Med; 1991; 36():329-62. PubMed ID: 2024585
    [No Abstract]   [Full Text] [Related]  

  • 26. The therapeutic use of hematopoietic growth factors.
    Costa JJ
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):1-6. PubMed ID: 9449493
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical applications of the hematopoietic growth factors.
    Rowland P; Mirro J
    Curr Opin Hematol; 1994 Jul; 1(4):303-9. PubMed ID: 9371297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemopoietic growth factors: uses and misuses.
    Bronchud MH
    Eur J Cancer; 1995; 31A(5):813-4. PubMed ID: 7640064
    [No Abstract]   [Full Text] [Related]  

  • 29. Haemopoietic growth factors in the treatment of infection in non-neutropenic patients.
    Khwaja A; Linch DC
    J Antimicrob Chemother; 1994 Apr; 33(4):679-83. PubMed ID: 8056687
    [No Abstract]   [Full Text] [Related]  

  • 30. Regulatory issues involved in hematopoietic growth factor approval.
    Zoon KC; Cohen RB; Gerrard T
    Semin Oncol; 1992 Aug; 19(4):432-40. PubMed ID: 1380733
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical uses of hematopoietic growth hormones in HIV-related illnesses.
    Mitsuyasu RT
    AIDS Clin Rev; 1993-1994; ():189-212. PubMed ID: 7692940
    [No Abstract]   [Full Text] [Related]  

  • 32. Hematopoietic growth factors in cancer chemotherapy.
    Morstyn G; Foote M; Lieschke GJ
    Cancer Chemother Biol Response Modif; 1996; 16():295-314. PubMed ID: 8639388
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytokines and hematopoietins: physiology, pathophysiology, and potential as therapeutic agents.
    Mertelsmann R; Rosenthal FM; Lindemann A; Herrmann F
    Recent Results Cancer Res; 1991; 121():121-40. PubMed ID: 1857854
    [No Abstract]   [Full Text] [Related]  

  • 34. Recombinant hematopoietic growth factors in bone marrow transplantation.
    Nemunaitis J
    Cancer Treat Res; 1995; 76():225-48. PubMed ID: 7577337
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical applications of filgrastim and stem cell factor in vivo and in vitro.
    Morstyn G; Glaspy J; Shpall EJ; LeMaistre F; Briddell R; Menchaca D; Lill M; Jones RB; Tami J; Brown S
    J Hematother; 1994; 3(4):353-5. PubMed ID: 7537611
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of hematopoietic growth factors in the treatment of neoplastic diseases.
    St Onge J; Jacobson RJ
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):53-63. PubMed ID: 1380737
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.
    Rossi Ferrini P; Santini V; Ciolli S; Grossi A; Leoni F; Rafanelli D; Vannucchi AM
    Hematol Oncol; 1993; 11 Suppl 1():32-5. PubMed ID: 7683622
    [No Abstract]   [Full Text] [Related]  

  • 38. Hematopoietic growth factors in myelodysplastic syndromes.
    Blinder VS; Roboz GJ
    Curr Hematol Rep; 2003 Nov; 2(6):453-8. PubMed ID: 14561388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of in vivo administration of recombinant methionyl human stem cell factor on the number of human marrow hematopoietic stem cells.
    Tong J; Gordon MS; Srour EF; Cooper RJ; Orazi A; McNiece I; Hoffman R
    Trans Assoc Am Physicians; 1993; 106():134-44. PubMed ID: 7518622
    [No Abstract]   [Full Text] [Related]  

  • 40. Potential pharmacological interventions against hematotoxicity: an overview.
    Shukla P; Singh R
    Expert Rev Hematol; 2015 Aug; 8(4):505-14. PubMed ID: 25843128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.